Skip to content

Effect of Alveolar Ridge Preservation on Implant Esthetic Outcomes

Esthetic Outcomes of Implant-supported Crowns After Alveolar Ridge Preservation With Beta Tricalcium Phosphate and Collagen in the Maxillary Esthetic Zone

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02507661
Enrollment
50
Registered
2015-07-24
Start date
2015-06-30
Completion date
2018-01-31
Last updated
2018-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Partial Edentulism

Brief summary

The purpose of this study is to evaluate esthetic outcome of implant supported single crowns after alveolar ridge preservation with beta three calcium phosphate with collagen type I in aesthetic region in upper jaw.

Interventions

DRUGpreservation of alveolar ridge with beta tricalcium phosphate + collagen - 2 months
DRUGno-preservation of alveolar ridge - 2 months
DRUGpreservation of alveolar ridge with beta tricalcium phosphate + collagen - 4 months
DRUGno-preservation of alveolar ridge - 4 months
PROCEDUREpreservation of alveolar ridge with beta tricalcium phosphate + collagen - 9 months
DRUGno-preservation of alveolar ridge - 9 months

Sponsors

University of Belgrade
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy patients according to Classification of American Society of Anesthesiologists (ASA I) * presence of 4 socket walls * non-smokers * good oral hygiene * good occlusion

Exclusion criteria

* patients with alveolar ridge height less than 12 mm * presence of acute or chronic oro-facial pain * acute periapical infection * injured soft tissue * patients who had dental interventions in last 7 days * patients who had any medications within last 24 hours * patients with bruxism and para-functions * patients with allergies to any of applied materials

Design outcomes

Primary

MeasureTime frameDescription
change in pink and white esthetic score 12 months of loading12 monthsPink esthetic scale and white esthetic scale will be used for evaluation of changes in white and pink esthetic parameters for implant-supported crowns
implant stability analysis 8 weeks after implant placementbaseline, 8 weeksImplant stability will be measured by the resonance frequency analysis
change in pink and white esthetic score 2 months of loading2 monthsPink esthetic scale and white esthetic scale will be used for evaluation of changes in white and pink esthetic parameters for implant-supported crowns
change in pink and white esthetic score 6 months of loading6 monthsPink esthetic scale and white esthetic scale will be used for evaluation of changes in white and pink esthetic parameters for implant-supported crowns
implant stability analysis at the time of implant placementbaselineImplant stability will be measured by the resonance frequency analysis
implant stability analysis 3 weeks after implant placementbaseline, 3 weeksImplant stability will be measured by the resonance frequency analysis
implant stability analysis 6 weeks after implant placementbaseline, 6 weeksImplant stability will be measured by the resonance frequency analysis

Secondary

MeasureTime frameDescription
analysis of new bone formation 4 months after preservation of alveolar ridge4 monthsNew bone formation will be assessed by histological analysis and histomorphometrical measurement
analysis of new bone formation 9 months after preservation of alveolar ridge9 monthsNew bone formation will be assessed by histological analysis and histomorphometrical measurement
analysis of new bone formation 2 months after preservation of alveolar ridge2 monthsNew bone formation will be assessed by histological analysis and histomorphometrical measurement

Countries

Serbia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026